NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/29/22

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2021 Earnings Conference Call March 29, 2022 16:30 ET Company Participants Jody Cain - Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Ladenbur...

NovaBay press release (NYSE:NBY): Q4 GAAP EPS of -$0.02 beats by $0.03. Revenue of $2.64M (+39.7% Y/Y) misses by $0.71M. Shares +1.56%. For further details see: NovaBay GAAP EPS of -$0.02 beats by $0.03, revenue of $2.64M misses by $0.71M

Fourth quarter net product revenue increased 40% on record Avenova spray unit sales 2021 Avenova spray net revenue increased 15% on 31% growth in unit sales 2020 net product revenue boosted by $3.1 million in non-recurring PPE product sales Company executing ...

AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...

NovaBay (NYSE:NBY) is scheduled to announce Q4 earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$0.05 (-25.0% Y/Y) and the consensus Revenue Estimate is $3.35M (+77.2% Y/Y). For further details see: NovaBay Q4 2021 Earnings Preview

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2021 after market close on Tuesday, March 29, 2022 and will hold an investment community conference call that day beginning at...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Let’s start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday! Source: Shutterstock The biggest news moving stocks this morning a...

NovaBay Pharmaceuticals (NYSE:NBY) launched Moisture Recovery HA Serum as the newest expansion to its Calm Cool + Corrected product line. The company said Moisture Recovery HA Serum is a formulation of hyaluronic acid, Vitamin C, Dragon Fruit and water-binding cactus botanicals to restore par...

New oil-free moisturizer is formulated with hyaluronic acid (HA), Vitamin C and unique botanical boosters to hydrate and repair the most challenged, dry, eczema-prone skin NovaBay® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and ...

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured in Premier Show on March 1 at 10 p.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulat...